INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 47m ago
HOUSE PTR7m ago
SEC 13F7m ago
ROBINHOOD CHAIN7m ago
Public company

HALOZYME THERAPEUTICS, INC.

HALOCIK 0001159036

EDGAR filingsOpen in network
Price$103.63
1 year+51.7%
Disclosed transactions2
Buys / sells1 / 1
Max Insider Score27
Connections with evidence3

HALO · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
Gilbert Ray Cisneros, Jr.DSelf
HALOHALOZYME THERAPEUTICS, INC.
Partial sale
SELL$1,001 – $15KSep 29, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Sale disclosed 2026-10-12 · Oct 12, 2026
  • ← Lobbied forevidence
    FORBES-TATELDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
Oct 12, 2026
traded Sep 29, 2026
+13d
HOUSE PTR

Evidence

24
Gilbert Ray Cisneros, Jr.DSelf
HALOHALOZYME THERAPEUTICS, INC.
Purchase
BUY$1,001 – $15KMar 9, 2026Apr 7, 2026
traded Mar 9, 2026
+29dHOUSE PTR

Evidence

Lobbying

$150K reported · de-duplicated
2026 Q2 $80K via firms2026 Q1 $70K via firms
  • FORBES-TATE$70K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
  • FORBES-TATE$80K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.